drugset / Trial / NCT06224777

Comparison of Fluid Resuscitation in Pediatric Burn Patients Using Crystalloids and With Albumin on Day Two.

NCT06224777 ↗

Phase 2/3 Completed 90 enrolled King Edward Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this comparative, interventional randomized controlled trial is to use albumin during resuscitation in pediatric burn patients on day 2, as it can reduce extravasation of fluids and decrease the overall fluid requirements, along with mortality and maintain circulation. Participants will be divided into 2 groups. Albumin will be administered additionally in group A, while only crystalloids will be used for resuscitation in group B.

Timeline

Start
2022-01-01
Primary completion
2022-12-18
Completion
2023-05-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Albumin Protein / enzyme biologic 0.5 unknown —
Background Paeds solution Unknown 20 unknown —
Background Paeds solution Unknown 50 unknown —
Background Paeds solution Unknown 100 unknown —

Indications

No indication recorded.